MCV-type II Chemokine-like Protein Antibody [CoraFluor™ 1]
Novus Biologicals, part of Bio-Techne | Catalog # AF697CL1
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Specificity
Clonality
Host
Isotype
Description
CoraFluor(TM) 1, amine reactive
CoraFluor(TM) 1, thiol reactive
For more information, please see our CoraFluor(TM) TR-FRET technology flyer.
Scientific Data Images for MCV-type II Chemokine-like Protein Antibody [CoraFluor™ 1]
Product Feature: CoraFluor Probes for TR-FRET
CoraFluor™ 1, amine reactive (Catalog:7920) and CoraFluor™ 2, amine reactive (Catalog # 7950) are terbium-based probes that have been developed for use as TR-FRET donors. They emit wavelengths compatible with commonly used fluorescent acceptor dyes such as BODIPY® (or BDY) and Janelia Fluor® dyes, FITC (Catalog # 5440), TMR and Cyanine 5 (Catalog # 5436). CoraFluor™ fluorescence is brighter and more stable in biological media than existing TR-FRET donors, leading to enhanced sensitivity and improved data generation. CoraFluor™ 1 exhibits excitation upon exposure to a 337 nm UV laser.Applications for MCV-type II Chemokine-like Protein Antibody [CoraFluor™ 1]
Western Blot
Neutralization
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: MCV-type II Chemokine-like Protein
Molluscum contagiosum virus (MCV) is a human cutaneous poxvirus that has been shown to encode homologs of cellular immunomodulatory proteins. MC148R2 is a CC chemokine-like protein encoded by an MCV type II gene. MC148R2 is a 104 amino acid (aa) protein containing a 24 aa signal peptide that is cleaved to produce an 80 aa mature protein.
Long Name
Alternate Names
Additional MCV-type II Chemokine-like Protein Products
Product Documents for MCV-type II Chemokine-like Protein Antibody [CoraFluor™ 1]
Product Specific Notices for MCV-type II Chemokine-like Protein Antibody [CoraFluor™ 1]
CoraFluor (TM) is a trademark of Bio-Techne Corp. Sold for research purposes only under agreement from Massachusetts General Hospital. US patent 2022/0025254
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.